• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育相关剪接调节视网膜中的垂体腺苷酸环化酶激活肽(PACAP)受体。

Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina.

机构信息

Department of Experimental Zoology and Neurobiology, University of Pécs, Pécs, Hungary.

出版信息

Invest Ophthalmol Vis Sci. 2012 Nov 27;53(12):7825-32. doi: 10.1167/iovs.12-10417.

DOI:10.1167/iovs.12-10417
PMID:23099490
Abstract

PURPOSE

The ubiquitous pituitary adenylate cyclase-activating peptide (PACAP) has a disparate array of functions in development (e.g., proliferation and apoptosis). Among three types of PACAP receptor (VPAC1, VPAC2, and PAC1), PAC1 is subject to alternative splicing that generates isoforms. Although the literature documenting the presence of PACAP receptors in the central nervous system is vast, their expression during development has not been established yet. Here, we performed quantitative analyses on the expression of PACAP receptors during the postnatal development of the rat retina.

METHODS

Retinas were harvested from postnatal days 0 to 20 (P0-P20). Using a comprehensive primer system, expression changes were followed employing quantitative real-time PCR. Changes at the protein level were detected by immunoblotting using anti-VPAC1, -VPAC2, and -PAC1 receptor antibodies.

RESULTS

The expression of VPAC1 showed increases at P10 and P15. Peaks in VPAC2 expression were observed at P5 and P15. Using splicing variant-specific primers for PAC1 receptor, splicing regulation of Null, Hip, Hop1, and Hiphop1 variants was revealed in correlation with postnatal development. Transcript levels of the Null and Hip variants showed a decline, while Hop1 became the major PACAP receptor by P20. Hiphop1 transcript levels did not display remarkable changes except for a transient increase at P10. Immunoblotting confirmed the presence and expression level changes of the receptors.

CONCLUSIONS

We conclude that both VPAC1 and VPAC2 could have roles at all stages of retinal development, that PACAP acts through a specific set of PAC1 isoforms, and that Hip and Hop1 are predominantly involved in the postnatal development of rat retina.

摘要

目的

普遍存在的垂体腺苷酸环化酶激活肽(PACAP)在发育过程中具有多种功能(例如,增殖和凋亡)。在三种类型的 PACAP 受体(VPAC1、VPAC2 和 PAC1)中,PAC1 可进行选择性剪接,从而产生同工型。尽管文献中记录了中枢神经系统中存在 PACAP 受体,但它们在发育过程中的表达尚未确定。在这里,我们对大鼠视网膜出生后发育过程中 PACAP 受体的表达进行了定量分析。

方法

从出生后第 0 天到第 20 天(P0-P20)收获视网膜。使用全面的引物系统,通过定量实时 PCR 跟踪表达变化。通过使用抗-VPAC1、-VPAC2 和-PAC1 受体抗体的免疫印迹检测蛋白质水平的变化。

结果

VPAC1 的表达在 P10 和 P15 时增加。VPAC2 表达的峰值出现在 P5 和 P15。使用 PAC1 受体的剪接变体特异性引物,揭示了 Null、Hip、Hop1 和 Hiphop1 变体的剪接调节与出生后发育相关。Null 和 Hip 变体的转录水平下降,而 Hop1 在 P20 时成为主要的 PACAP 受体。除了在 P10 时短暂增加外,Hiphop1 转录水平没有明显变化。免疫印迹证实了受体的存在和表达水平变化。

结论

我们得出结论,VPAC1 和 VPAC2 都可能在视网膜发育的所有阶段发挥作用,PACAP 通过特定的 PAC1 同工型发挥作用,Hip 和 Hop1 主要参与大鼠视网膜的出生后发育。

相似文献

1
Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina.发育相关剪接调节视网膜中的垂体腺苷酸环化酶激活肽(PACAP)受体。
Invest Ophthalmol Vis Sci. 2012 Nov 27;53(12):7825-32. doi: 10.1167/iovs.12-10417.
2
Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.垂体腺苷酸环化酶激活多肽及PACAP受体在大鼠肾上腺中的表达与功能
Int J Mol Med. 2002 Mar;9(3):233-43.
3
Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.发育过程中大鼠脑内垂体腺苷酸环化酶激活多肽(PACAP)结合位点及PACAP受体mRNA的比较分布
J Comp Neurol. 2000 Oct 2;425(4):495-509.
4
Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.垂体腺苷酸环化酶激活多肽、血管活性肠肽及其受体在小鼠卵巢中的表达定位与功能活性
Reproduction. 2007 Aug;134(2):281-92. doi: 10.1530/REP-07-0051.
5
Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.人正常乳腺组织和乳腺癌组织中的垂体腺苷酸环化酶激活肽/血管活性肠肽受体
Gynecol Endocrinol. 2005 Jun;20(6):327-33. doi: 10.1080/09513590500098240.
6
Differential expression of PACAP receptors in postnatal rat brain.PACAP 受体在新生大鼠脑内的差异表达。
Neuropeptides. 2010 Dec;44(6):509-14. doi: 10.1016/j.npep.2010.09.001. Epub 2010 Oct 23.
7
PAC1-expressing structures of neural retina alter their PAC1 isoform splicing during postnatal development.神经视网膜中表达 PAC1 的结构在出生后发育过程中改变其 PAC1 同工型的剪接。
Cell Tissue Res. 2014 Feb;355(2):279-88. doi: 10.1007/s00441-013-1761-0. Epub 2013 Dec 20.
8
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.早期糖尿病大鼠视网膜中垂体腺苷酸环化酶激活肽、血管活性肠肽及相关受体表达的变化。
Peptides. 2012 Sep;37(1):32-9. doi: 10.1016/j.peptides.2012.06.004. Epub 2012 Jun 18.
9
Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.垂体腺苷酸环化酶激活多肽(PACAP)及其在耳蜗中的受体(PAC1-R):大鼠显微解剖耳蜗亚组分中PAC1-R剪接变体特异性转录表达的证据。
Neuroscience. 2006 Jun 19;140(1):147-61. doi: 10.1016/j.neuroscience.2006.01.019. Epub 2006 Apr 19.
10
Identification of PAC1 receptor isoform mRNAs by real-time PCR in rat suprachiasmatic nucleus.通过实时聚合酶链反应在大鼠视交叉上核中鉴定PAC1受体亚型mRNA
Brain Res Mol Brain Res. 2002 Sep 30;105(1-2):29-37. doi: 10.1016/s0169-328x(02)00387-x.

引用本文的文献

1
Retinal VIP-amacrine cells: their development, structure, and function.视网膜 VIP 无长突细胞:它们的发育、结构和功能。
Eye (Lond). 2024 Apr;38(6):1065-1076. doi: 10.1038/s41433-023-02844-x. Epub 2023 Dec 8.
2
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.靶向 VIP 和 PACAP 受体信号:设计 PACAP 受体亚家族药物的新见解。
Int J Mol Sci. 2022 Jul 22;23(15):8069. doi: 10.3390/ijms23158069.
3
PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.
垂体腺苷酸环化酶激活肽与促肾上腺皮质激素释放因子:两种功能相关肽在糖尿病性视网膜病变中的作用
J Mol Neurosci. 2021 Aug;71(8):1525-1535. doi: 10.1007/s12031-020-01769-4. Epub 2021 Jan 5.
4
Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin.垂体腺苷酸环化酶激活多肽在代谢性视网膜变性中的神经保护潜力
Front Neurosci. 2019 Oct 9;13:1031. doi: 10.3389/fnins.2019.01031. eCollection 2019.
5
Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.垂体腺苷酸环化酶激活多肽:30年处于研究焦点,6亿年发挥作用。
J Clin Med. 2019 Sep 18;8(9):1488. doi: 10.3390/jcm8091488.
6
Effects of PACAP on Dry Eye Symptoms, and Possible Use for Therapeutic Application.PACAP 对干眼症症状的影响,以及在治疗应用中的可能用途。
J Mol Neurosci. 2019 Jul;68(3):420-426. doi: 10.1007/s12031-018-1087-1. Epub 2018 Jun 22.
7
Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.垂体腺苷酸环化酶激活多肽,一种用于大鼠糖尿病视网膜病变的潜在治疗药物:聚焦垂直信息处理通路。
Neurotox Res. 2016 Apr;29(3):432-46. doi: 10.1007/s12640-015-9593-1. Epub 2016 Jan 6.
8
Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Signal via Phospholipase C Pathway to Block Apoptosis in Newborn Rat Retina.垂体腺苷酸环化酶激活多肽受体通过磷脂酶C途径发出信号,以阻止新生大鼠视网膜细胞凋亡。
Neurochem Res. 2015 Jul;40(7):1402-9. doi: 10.1007/s11064-015-1607-0. Epub 2015 May 15.
9
Alternative splicing of the LIM-homeodomain transcription factor Isl1 in the mouse retina.小鼠视网膜中LIM同源结构域转录因子Isl1的可变剪接
Mol Cell Neurosci. 2015 Mar;65:102-13. doi: 10.1016/j.mcn.2015.03.006. Epub 2015 Mar 6.
10
Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.脑内活性精细调控的机制:垂体腺苷酸环化酶激活肽受体 PAC1 的可变剪接。
Front Endocrinol (Lausanne). 2013 May 21;4:55. doi: 10.3389/fendo.2013.00055. eCollection 2013.